Kolon Life Science apologizes for Invossa mislabeling, but insists drug was safe
IndustryJul 4, 2019
The chief of Kolon Life Science on Thursday reiterated the safety of the now-banned joint inflammation treatment Invossa, while apologizing for the market confusion and credibility depreciation. “As top representative, I deeply apologize on behalf of the company for causing worries and confusion to patients, investors and the medical circles,” said KLS CEO Lee Woo-suk in a press conference held at the Korea Press Center in downtown Seoul. The disputed mislabeling of the substance in